NCT00887159 2021-01-05A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive StageNational Cancer Institute (NCI)Phase 2 Completed168 enrolled 11 charts